AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Tenlivest-M Tablet ER

Prescription Icon
Prescription Required

Marketer

Vestal Lifesciences Pvt Ltd

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Tenlivest-M Tablet ER

Duo-Control ER tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This helps prevent severe diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risks. Duo-Control ER may be used alone or with other diabetes treatments. Optimal results require combining this medication with a balanced diet and regular physical activity. Dosage is personalized based on your health, blood sugar readings, and other medications. Consuming it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under your physician's guidance. It regulates blood sugar, mitigating future complications. Adherence to your doctor's dietary and exercise plan is crucial. Lifestyle significantly impacts diabetes management. Common side effects include nausea, vomiting, diarrhea, indigestion, and headache. Hypoglycemia is possible, especially with insulin or sulfonylurea use; learn its symptoms and management. This medication isn't for everyone. Inform your doctor about kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol use before starting. Pregnant or nursing individuals should consult their doctor. Interactions with other medications are possible; disclose all medications to ensure safety. Limit alcohol consumption to avoid further blood glucose reduction. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Primary Ingredients of Tenlivest-M Tablet ER

No information provided. Please provide the text you wish me to rephrase.

Uses of Tenlivest-M Tablet ER

Managing type 2 diabetes

Major Benefits of Tenlivest-M Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Tenlivest-M Extended-Release tablets with food.

Common Side effects of Tenlivest-M Tablet ER:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Tenlivest-M Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tenlivest-M Extended-Release Tablets should be taken with a meal.

How Tenlivest-M Tablet ER works:

Extended-release Tenlivest-M tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Tenlivest-M Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Tenlivest-M Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Tenlivest-M tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Tenlivest-M Tablet ER on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Tenlivest-M Tablet ER cautiously, potentially requiring a modified dosage. Severe kidney disease contraindicates its use. Physician consultation is necessary. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Extended-release Tenlivest-M tablets pose a likely risk for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Tenlivest-M Tablet ER :

Should you forget a Tenlivest-M Tablet ER dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tenlivest-M Tablet ER

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Tenlivest-M Tablet ER

Tenlivest-M Tablet ER is safe when used as directed by your doctor. However, even with proper usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent side effects to your physician.
Tenlivest-M Tablet ER rarely causes low blood sugar by itself, but this can happen if you don't eat enough while taking it. Low blood sugar symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. These symptoms are more likely if you skip meals, drink alcohol, overexert yourself, or use other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Tenlivest-M Tablet ER. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always consult your doctor before taking any other medication.
Tenlivest-M Tablet ER is contraindicated in patients with allergies to its components or excipients. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Tenlivest-M Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect characterized by elevated blood lactic acid. This risk is heightened in patients with kidney disease, the elderly, and heavy alcohol users, who should avoid this medication. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Tenlivest-M Tablet ER and seek immediate medical attention.
Prolonged Tenlivest-M Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may result in anemia, nerve damage (potentially causing tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and balance problems), necessitating medical attention. Symptoms warrant a doctor's consultation, who may recommend B12 level monitoring and supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Tenlivest-M Tablet ER
129
MRP 149
13% off